|
FUSN
|
Fusion Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
GALT
|
Galectin Therapeutics Inc.
|
US
|
NASDAQ
|
|
GMED
|
Globus Medical, Inc.
|
US
|
NYSE
|
|
GRTS
|
Gritstone Oncology, Inc.
|
US
|
NASDAQ
|
|
HARP
|
Harpoon Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HTGM
|
HTG Molecular Diagnostics, Inc.
|
US
|
NASDAQ
|
|
ICCM
|
IceCure Medical Ltd.
|
US
|
NASDAQ
|
|
IMNM
|
Immunome, Inc.
|
US
|
NASDAQ
|
|
IMNN
|
Imunon, Inc.
|
US
|
NASDAQ
|
|
INBS
|
Intelligent Bio Solutions Inc.
|
US
|
NASDAQ
|
|
INBX
|
Inhibrx, Inc.
|
US
|
NASDAQ
|
|
INDP
|
Indaptus Therapeutics, Inc.
|
US
|
NASDAQ
|
|
JANX
|
Janux Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MRKR
|
Marker Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NKTX
|
Nkarta, Inc.
|
US
|
NASDAQ
|
|
NVCR
|
NovoCure Limited
|
US
|
NASDAQ
|
|
NXTC
|
NextCure, Inc.
|
US
|
NASDAQ
|
|
POAI
|
Predictive Oncology Inc.
|
US
|
NASDAQ
|
|
PPBT
|
Purple Biotech Ltd.
|
US
|
NASDAQ
|
|
RAIN
|
Rain Therapeutics Inc.
|
US
|
NASDAQ
|